Ischemic myocardium-targeted NAD(+) nanotherapy mitigates myocardial ischemia/reperfusion injury.

Xie X, Zhang X, Zhou Z, Han C, Zeng K, Wang L, Chen J, Zhang Y, Zhang Y, Ye M

DOI: 10.1016/j.jconrel.2026.115454
Published: 2026 Nov 10
Container: Journal of controlled release : official journal of the Controlled Release Society
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jconrel.2026.115454,
  title = {Ischemic myocardium-targeted NAD(+) nanotherapy mitigates myocardial ischemia/reperfusion injury.},
  author = {Xie X and Zhang X and Zhou Z and Han C and Zeng K and Wang L and Chen J and Zhang Y and Zhang Y and Ye M},
  year = {2026},
  journal = {Journal of controlled release : official journal of the Controlled Release Society},
  doi = {10.1016/j.jconrel.2026.115454},
  url = {https://doi.org/10.1016/j.jconrel.2026.115454}
}

RIS

TY  - JOUR
TI  - Ischemic myocardium-targeted NAD(+) nanotherapy mitigates myocardial ischemia/reperfusion injury.
AU  - Xie X
AU  - Zhang X
AU  - Zhou Z
AU  - Han C
AU  - Zeng K
AU  - Wang L
AU  - Chen J
AU  - Zhang Y
AU  - Zhang Y
AU  - Ye M
PY  - 2026
JO  - Journal of controlled release : official journal of the Controlled Release Society
DO  - 10.1016/j.jconrel.2026.115454
UR  - https://doi.org/10.1016/j.jconrel.2026.115454
ER  -

APA

X, X., X, Z., Z, Z., C, H., K, Z., L, W., J, C., Y, Z., Y, Z., & M, Y. (2026). Ischemic myocardium-targeted NAD(+) nanotherapy mitigates myocardial ischemia/reperfusion injury.. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2026.115454

Source records

pubmed · retrieved 2026-11-10T11:04:35.818Z